Top compounds associated with response to SYT14


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0009
mRNA JNK-9L GDSC1000 pan-cancer AAC -0.12 0.0009
mRNA CIL70 CTRPv2 pan-cancer AAC 0.16 0.001
mRNA Tipifarnib GDSC1000 pan-cancer AAC -0.12 0.001
mRNA JW-74 CTRPv2 pan-cancer AAC 0.15 0.001
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA AZD6482 GDSC1000 pan-cancer AAC -0.11 0.001
mRNA CIL41 CTRPv2 pan-cancer AAC 0.17 0.001
mRNA NVP-BEZ235 GDSC1000 pan-cancer AAC -0.11 0.002
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC 0.13 0.002
Download CSV